LUPIN LTD.
Lupin Ltd. is one of India's leading pharmaceutical companies, renowned for its innovation, quality, and commitment to healthcare. Established in 1968, Lupin has grown to become a global player in the pharmaceutical industry, with a presence in over 100 countries. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic medicines, branded formulations, and biotechnology products. Lupin's portfolio encompasses therapeutic areas such as cardiology, diabetology, asthma, pediatrics, central nervous system (CNS), gastroenterology, anti-infectives, and nonsteroidal anti-inflammatory drugs (NSAIDs). The company's dedication to research and development has led to numerous breakthroughs and innovations in the healthcare sector. With a strong emphasis on quality and compliance, Lupin's manufacturing facilities are accredited by major global regulatory agencies, including the U.S. FDA, WHO, and EMA. The company's robust supply chain ensures the timely delivery of high-quality products to patients worldwide. Lupin's mission is to improve the quality of human life by providing affordable and accessible healthcare solutions. The company's vision is to be an innovation-led transnational pharmaceutical company, dedicated to delivering exceptional value to its customers and stakeholders.